Can cholesterol medicine cause constipation
Pro Research Analysisby 
Searched over 200M research papers
Cholesterol Medicine and Constipation: An Overview
Introduction to Cholesterol Medications and Constipation
Cholesterol-lowering medications are widely used to manage hypercholesterolemia and reduce the risk of cardiovascular diseases. However, these medications can sometimes lead to gastrointestinal side effects, including constipation. This article explores the relationship between various cholesterol medications and constipation, drawing on multiple research studies.
Statins and Constipation
Atorvastatin and Constipation
Atorvastatin, a commonly prescribed statin, has been reported to cause constipation in some patients. A case study involving a 72-year-old patient with hypercholesterolemia revealed that the patient developed constipation and abdominal discomfort after starting Atorvastatin 20 mg. The symptoms improved after discontinuing Atorvastatin and switching to Rosuvastatin, suggesting a direct link between Atorvastatin and constipation .
Bile Acid Sequestrants and Constipation
Colestipol and Constipation
Bile acid sequestrants, such as colestipol, are another class of cholesterol-lowering drugs known to cause constipation. In a study involving 66 hypercholesterolemic patients, colestipol was found to lower serum cholesterol significantly. However, constipation was reported as a common side effect, affecting six patients on colestipol compared to three on placebo . This highlights the potential for bile acid sequestrants to induce constipation.
Cholestyramine and Colesevelam
Similarly, cholestyramine and colesevelam, other bile acid sequestrants, have been associated with constipation. These medications can alter the physicochemical properties of intestinal contents, leading to constipation and, in rare cases, intestinal obstruction . Despite their efficacy in lowering cholesterol, their gastrointestinal side effects warrant careful consideration.
Cholesterol Absorption Inhibitors and Constipation
Ezetimibe
Ezetimibe, a cholesterol absorption inhibitor, has a favorable safety profile with minimal gastrointestinal side effects. Clinical trials have not shown a significant increase in constipation rates with ezetimibe, making it a safer option for patients concerned about constipation .
Managing Constipation in Patients on Cholesterol Medications
Dietary Interventions
Dietary interventions, such as the use of isomalto-oligosaccharides (IO) and psyllium, have shown promise in managing constipation in patients on cholesterol-lowering medications. IO supplementation improved bowel function and colonic microflora in constipated elderly subjects, while also lowering plasma cholesterol levels . Similarly, psyllium supplementation improved constipation symptoms and lipid profiles in patients with type 2 diabetes and chronic constipation .
Flaxseed
Flaxseed has also been effective in managing constipation and improving lipid profiles. A study involving constipated patients with type 2 diabetes found that flaxseed supplementation significantly improved constipation symptoms and reduced cholesterol levels .
Conclusion
Cholesterol-lowering medications, particularly statins like Atorvastatin and bile acid sequestrants like colestipol and cholestyramine, can cause constipation in some patients. However, not all cholesterol medications have this side effect, with ezetimibe being a notable exception. Managing constipation through dietary interventions, such as IO, psyllium, and flaxseed, can help mitigate these side effects while maintaining effective cholesterol control. Patients experiencing constipation should consult their healthcare provider to adjust their treatment plan accordingly.
Sources and full results
Most relevant research papers on this topic
Cholesterol-lowering effect of colestipol hydrochloride given twice daily in hypercholesterolemic patients.
Colestipol hydrochloride, 10g twice daily, effectively lowers serum cholesterol in hypercholesterolemic patients, with the most common side effect being constipation.
Safety considerations with gastrointestinally active lipid-lowering drugs.
Gastrointestinally active lipid-lowering drugs, such as ezetimibe and colesevelam, have excellent systemic safety profiles when used alone or in combination with other lipid-lowering drugs.
Effects of psyllium vs. placebo on constipation, weight, glycemia, and lipids: A randomized trial in patients with type 2 diabetes and chronic constipation.
Psyllium supplementation in patients with type 2 diabetes and chronic constipation decreased constipation symptoms, body weight, glycemic, cholesterol, and increased HDLC levels without adverse effects.
Intestinal transit, deoxycholic acid and the cholesterol saturation of bile--three inter-related factors.
Constipation or slow colonic transit may increase the risk of supersaturated bile, leading to gall stones, by altering the size of the deoxycholic acid pool and bile cholesterol saturation.
A randomized trial of the effects of flaxseed to manage constipation, weight, glycemia, and lipids in constipated patients with type 2 diabetes
Flaxseed cookies, when used as a snack, may help decrease constipation symptoms, weight, glycemic, and lipid levels in patients with type 2 diabetes.
Use of isomalto-oligosaccharide in the treatment of lipid profiles and constipation in hemodialysis patients.
Isomalto-oligosaccharide (IMO) effectively increases bowel frequency and improves constipation in hemodialysis patients, while also lowering total cholesterol and triglycerides and raising HDL-C levels.
DOI